We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
79 hedge funds and large institutions have $644M invested in Revance Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
554% more call options, than puts
Call options by funds: $6.6M | Put options by funds: $1.01M
89% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 19
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $655M → $644M (-$10.9M)
10% less funds holding
Funds holding: 88 → 79 (-9)
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Holders
79
Holders Change
-9
Holders Change %
-10.23%
% of All Funds
2.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
9
Increased
36
Reduced
19
Closed
18
Calls
$6.6M
Puts
$1.01M
Net Calls
+$5.59M
Net Calls Change
+$3.69M
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.61M |
| 2 |
Morgan Stanley
New York
|
-$1.7M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.65M |
| 4 |
Renaissance Technologies
New York
|
-$1.25M |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
-$1.09M |
